Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Prostatic Neoplasms 8 Neoplasms 5 Lung Neoplasms 5 Head and Neck Neoplasms 5 Leukemia, Myeloid, Acute 4 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Recurrence 2 Pulmonary Disease, Chronic Obstructive 2 Neoplasm Metastasis 2 Lymphoma, Follicular 2 Leukemia 2 Colonic Neoplasms 2 COVID-19 2 Xerostomia 1 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Stroke 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1

Interventions

Cyclophosphamide 60 Vincristine 57 Doxorubicin 54 Rituximab 48 Prednisone 44 Etoposide 35 Radiotherapy 34 Cytarabine 26 Filgrastim 22 Methotrexate 21 Bleomycin 21 Dexamethasone 18 Peripheral Blood Stem Cell Transplantation 14 Carmustine 14 Vinblastine 13 Prednisolone 13 VAP-cyclo protocol 12 Melphalan 12 Mitoxantrone 11 Mercaptopurine 10 Leucovorin 10 Dacarbazine 9 Ifosfamide 8 Granulocyte Colony-Stimulating Factor 8 Procarbazine 7 Methylprednisolone 7 Lenalidomide 7 Gemcitabine 7 Daunorubicin 7 Cisplatin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma × Standard of Care × Clear all

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡